Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

Status:	Completed
Conditions:	Cardiology, Ocular, Diabetes
Therapuetic Areas:	Cardiology / Vascular Diseases, Endocrinology, Ophthalmology
Healthy:	No
Age Range:	21 - Any
Updated:	4/21/2016
Start Date:	October 2012
End Date:	November 2012

To conduct a precision study to assess the microperimetry function of the Spectral OCT/SLO.
The study will assess variability across measurements taken by three different
operator-device configuration across clinical sites, variability between subjects within a
given operator-device configuration, and variability within a subject for a single
operator-device configuration.

Inclusion Criteria:

- Subject must be 21 years of age or older.

- Subjects recruited to Cohort 1 will have no known retinal disease except for
refractive errors (-7.5 D to +7.5 diopters).Subjects who are recruited to Cohort 2
will have one or more of the following retinal pathologies: early and intermediate
Age-Related Macular Degeneration, Geographic Atrophy, Diabetic Retinopathy (mild,
moderate, severe), Macular Edema secondary to Diabetes, Retinal Vein Occlusion,
Central Serous Retinopathy, Pattern Dystrophy, Epiretinal Membrane or Macular Hole.

- Subjects who have signed an informed consent form.

- Subjects who can comply with the protocol.

Exclusion Criteria:

- Subjects younger than 21 years of age.

- Subjects who cannot comply with the protocol.

- Subjects who cannot complete the Simple Test procedures

- Subjects who are not available to be testing 3 times during the day (Morning, Mid -
Day, and Afternoon).

- Subjects with visual acuity worse than 20/100 (Best Corrected).

- Subjects with dense media opacities.

- Ocular surgery anticipated on the day of the study visit.

We found this trial at

sites

Retina Group of Florida

Fort Lauderdale, Florida 33334

from

Fort Lauderdale, FL